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Abstract— Objective: Muscle contractions are commonly 
detected by performing EMG measurements. The major 
disadvantage of this technique is that mechanical disturbances to 
the electrodes are in the same frequency and magnitude range as 
the desired signal.  In this work we propose an approach and a 
realized measurement system to combine EMG and bioimpedance 
measurements for higher reliabilities of muscle contraction 
detections. Methods: We propose the development of a modular 
four-channel measurement system, whereat each channel is 
capable of acquiring EMG, the bioimpedance magnitude and 
phase, simultaneously. The modules are synchronized by an 
additional interface board, which communicates with a PC. A 
graphical user interface enables to control the bioimpedance 
excitation current in a range from 100 µA to 1 mA in a frequency 
range from 50 kHz to 333 kHz. Results: A system characterization 
demonstrated that bioimpedance magnitude changes of less than 
250 ppm and phase changes below 0.05° can be detected reliably. 
Measurements from a subject have shown the timing relationship 
between EMG and bioimpedance signals as well as their 
robustness against mechanical disturbances. A measurement of 
five exemplary hand gestures has demonstrated the increase of 
usable information for detecting muscle contractions. Conclusion: 
Bioimpedance measurements of muscles provide useful 
information about contractions. Furthermore, the usage of a 
known high-frequency excitation current enables a reliable 
differentiation between the actual information and disturbances. 
Significance: By combining EMG and bioimpedance 
measurements, muscle contractions can be detected much more 
reliably. This setup can be adopted to prostheses and many other 
human-computer interfaces. 
 
Index Terms—Bioimpedance measurements, electrode-skin 
contact, electromyography, human-computer interaction, I/Q-
demodulation, motion artifacts, multi-channel, muscle 
contractions, prosthesis control. 
I. INTRODUCTION 
N the past several years the detection of muscle contractions 
has become an important technique in biomedical 
engineering. It can either be acquired at a single position of the 
body to analyze the state of a single muscle (group) or it is 
acquired at different positions simultaneously. The gathered 
information is commonly used to control computer systems, 
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robots, exoskeletons or prostheses [1], [2], [3]. Especially for 
the last example, a high reliability is important to avoid 
misinterpretations of the signals, which could cause dangerous 
situations to the user. 
The commonly used measurement technique to detect muscle 
contractions is the Electromyography (EMG) [4]. This method 
is based on acquiring the action potentials of the contracted 
muscles [5]. Typically, these signals result in differential 
voltages in millivolt ranges at the body surface and can be 
acquired using surface electrodes [6]. Since the most dominant 
signal frequency range is from 10 Hz up to 100 Hz [7], the 
electrical measurement instrumentation can be very elementary. 
Further methods to detect muscle contractions are the 
mechanomyography (MMG) [8] and optical setups [9]. 
Algorithms to combine a set of several signals to get 
information about movements are often machine-learning 
based [10]. 
One of the most challenging problems are motion artifacts, 
since the fixation of optical, ultrasound or acceleration sensors 
to the human body is problematic. But also the most commonly 
acquired EMG signal is very sensitive to motion artifacts [11]. 
Especially, forces to the electrode-skin interfaces result in 
significant signal disturbances [12]. Since these disturbances 
are in a similar frequency range like the actual EMG signal, it 
is difficult to differentiate between both of them. 
A promising measurement technique which might be more 
robust towards these disturbances is the electrical impedance 
myography (EIM). This technique is based on measuring the 
changes of the muscles’ electrical bioimpedance, which occur 
during muscle contractions, caused by geometrical changes 
[13], [14]. The major advantage of this measurement method is 
that muscle contraction information is modulated onto an 
excitation current of much higher frequency than that of motion 
artifacts. Therefore, the subsequent filtering of motion artifacts 
is very simple. Obviously, it is also advantageous to extend the 
EMG information by the two additional dimensions of 
information, the magnitude and the phase of the bioimpedance 
(BioZ). 
In this work, we propose a measurement method to acquire 
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EMG signals as well as bioimpedance signals simultaneously 
from the human body to increase the reliability of muscle 
contraction detections. After explaining the measurement 
approach, we describe the development of a four-channel 
measurement system, capable of acquiring the EMG signal and 
the magnitude as well as the phase of the bioimpedance at four 
different positions of the human body. The developed system is 
focused, but not limited to the usage in combination with upper 
limb prostheses. 
After a system characterization, measurements from a human 
subject demonstrate the behavior of EIM signals in comparison 
to EMG signals. Additionally, the robustness towards motion 
artifacts of both the methods is shown. Finally, all four channels 
are used to measure five common hand gestures and to compare 
the resulting signals. For comparison purposes, this 
measurement is repeated for two isometric hand gestures.  
II. MEASUREMENT APPROACH 
Although, the EMG as well as the EIM signals contain 
information about the muscle state, the origins of both the 
signals are different. The EMG signal, acquired by means of 
surface electrodes, is the summation of single fiber potentials 
of a muscle [15]. Activating the muscle results in measureable 
voltage amplitudes of up to 2 mV [5] in the frequency range 
below 100 Hz [7]. 
The EIM is based on the fact, that geometrical changes 
during muscle contractions cause changes in the electrical 
impedance of the observed muscle. Since the muscle is a very 
anisotropic conductor, this effect depends on the positioning of 
the electrodes [14]. 
The major difference between both the signals is, that EMG 
detects muscle activations, whereas EIM detects actual muscle 
contractions. 
The approach of measuring both signals simultaneously is 
depicted in Fig. 1, in which the EMG signal is modelled as a 
voltage source VEMG and the bioimpedance is represented by an 
impedance ZBio. Via the electrodes E1 and E2, a small known 
AC current IBioZ with a frequency in kHz range is applied to the 
tissue under test. This current flows through the EMG voltage 
source and the bioimpedance. Two additional electrodes (E3 
and E4) are used do acquire the occurring voltage drop. Because 
of the significant influence of the electrode-skin interfaces [16], 
the electrodes are modelled as serial circuits consisting of 
electrode-skin impedances (ZESI) and DC voltage sources 
(VHC), representing the occurring half-cell voltages. Assuming 
the input impedance of the differential amplifiers to be infinity, 
this model leads to the actual measurable addition of voltages 
with different frequencies, as shown in equation 1. 
 
𝑉𝑉𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀. = 𝑉𝑉𝐸𝐸𝑀𝑀𝐸𝐸 + 𝑍𝑍𝐵𝐵𝐵𝐵𝐵𝐵 ⋅ 𝐼𝐼𝐵𝐵𝐵𝐵𝐵𝐵𝐵𝐵 + 𝑉𝑉𝐻𝐻𝐶𝐶,𝑉𝑉+ − 𝑉𝑉𝐻𝐻𝐶𝐶,𝑉𝑉−   (1) 
 
Two different paths of signal processing, each beginning 
with amplification, are applied for the EMG and bioimpedance 
signal extraction, respectively. 
For obtaining the EMG signal and removing high frequency 
disturbances as generated by the EIM, a band pass filter 
(BPEMG) is used. When VHC,V+ and VHC,V- are DC voltages, the 
band pass filter attenuates also these signal components. 
However, if mechanical forces, applied to the electrodes, 
change the half-cell voltages quickly over time, the occurring 
AC voltages are not removed anymore. 
The bioimpedance path includes a band pass filter (BPBioZ) 
for removing undesirable frequency components as well. The 
commonly used frequency range of bioimpedance 
measurements is much higher than that of typical motion 
artifacts [16], [11]. Therefore, the lower cut-off frequency of 
the filter is much higher than the frequency range of the 
occurring disturbances. To calculate the bioimpedance 
magnitude |ZBio| and phase ϕ(ZBio), the signal is demodulated 
by an IQ (In-phase and Quadrature)-demodulation in 
combination with low pass filters. Since this demodulation 
technique utilizes the knowledge about the excitation frequency 
of the current source (IBioZ), other frequency components are 
cancelled out.  
III. SYSTEM DEVELOPMENT 
To allow a high flexibility regarding the number of channels, 
a modular four-channel measurement system was designed. 
Significant requirements were the synchronicity of EMG and 
 
Fig. 1.  Illustration of the simplified measurement approach. The blue ellipses 
represent the electrical behavior of the electrode-skin interfaces. The current 
source IBioZ is part of the electrical circuitry, whereas the voltage source VEMG 
symbolizes the EMG signal source of the muscle.  
  
 
Fig. 2.  Block diagram of the whole developed measurement system with a 
focus on the interface board, which connects a host PC with the four 
measurement modules. The red bar illustrates the galvanic isolation barrier of 
8 mm width to fulfill the IEC60601-1. The blue arrows indicate the exchange 
of data and the green arrows represent the power supply connections, which 
decouple the modules electrically from each other. For the same reason, the 
yellow synchronization connections are interrupted by digital isolators as well. 
This is the author's version of an article that has been published in this journal. Changes were made to this version by the publisher prior to publication.
The final version of record is available at  http://dx.doi.org/10.1109/JSEN.2019.2936171
Copyright (c) 2019 IEEE. Personal use is permitted. For any other purposes, permission must be obtained from the IEEE by emailing pubs-permissions@ieee.org.
EIM measurements as well as the medical electrical safety. 
Since the device is intended to measure bioimpedances at 
several points of the subject simultaneously, a galvanic 
decoupling of all channels had to be implemented [17].  
After an overview of the whole system, the developed 
measurement modules are explained more detailed. Finally, the 
realization of the device is presented. 
A. Concept 
In Fig. 2, the block diagram of the developed measurement 
system is depicted. It consists mainly of an interface board and 
four measurement modules. The interface board is intended to 
convert the USB interface of a linked host PC to four UART 
connections for the measurement modules. In accordance with 
the safety requirements for medical electrical devices (IEC 
60601-1) the measurement modules together with their 
connection on the interface board are regarded as Applied Parts, 
which need to be isolated. The isolation for data transport is 
accomplished by digital isolators (ISO7721, Texas Instruments, 
Dallas, TX, US) which realize an 8 mm isolation gap. For 
powering the measurement system, an external 5 VDC medical 
power supply is used (MPU31-102, SINPRO Electronics, 
Pingtung City, TW). To decouple the measurement channels 
from each other, necessary ±5 VDC supply voltages are 
generated separately via isolated DC/DC converters 
(MTU2D0505, Murata Power Solutions, Westborough, MA, 
US). 
Synchronizing all boards is realized by a common 
synchronization clock, which is generated by a microcontroller 
(ATSAM4S16C, Microchip Technology, Chandler, AZ, US) 
and transmitted via digital isolators (MAX14930, Maxim 
Integrated, San Jose, CA, US) to the measurement modules. 
B. Measurement Modules 
Each measurement module is intended to acquire an EMG 
signal and the complex bioimpedance from a human subject 
simultaneously. Since the modules are also intended to be used 
in combination with other devices like prostheses, the data 
interface is desired to be simple. 
The EMG signal characteristic is well known and has already 
been described above. However, the exact impedance behavior 
of the muscle during contractions is difficult to predict. In 
literature, impedance changes in the range from about 1 % to 
5 % have been reported [18]. These values can vary widely and 
depend on the specific measurement setup and the used 
excitation frequency. Therefore, the EIM circuitry has to be 
flexible regarding excitation frequency and impedance range. 
Based on these requirements, the measurement modules were 
developed. 
In Fig. 3, the block diagram of a measurement module is 
shown. After receiving the configuration data from the 
previously described interface board, the microcontroller’s 
(ATSAM4S16C, Microchip Technology, Chandler, AZ, US) 
digital-to-analog converter (DAC) generates a sinusoidal 
voltage in the frequency range from 50 kHz to 333 kHz with a 
sampling rate of 1 MSPS. In this band, the bioimpedance is very 
sensitive against frequency changes [16]. An active low-pass 
filter (LPDAC, N=4, fc=350 kHz) attenuates the DAC artifacts 
and a passive high-pass filter (HPDAC, N=1, fc=200 Hz) removes 
the DC component. Utilizing a voltage-controlled current 
source (VCCS) circuit [17], [19], this AC voltage is converted 
into an AC current. This current flows via electrodes through 
the examined bioimpedance (ZBio) and a known shunt resistor 
(RS). 
The occurring voltage drop over the bioimpedance, caused 
by the excitation current, as well as the superposition of the 
EMG voltage, is detected by two additional inner electrodes. 
 
Fig. 3.  Detailed block diagram of a measurement module. On the left side there are the connections to the previously described interface board. On the right 
side the connected measurement subject, which is connected via electrodes, is drawn. The measurement module consists of a microcontroller, a power section, 
an analog-to-digital converter and three major analog electronics blocks. The blue block marks the current source circuit, the green rectangle illustrates the 
EMG circuit and the red area indicates the bioimpedance measurement circuit, which is based on an IQ-demodulation. 
  
 
Fig. 4.  Photograph of the interface board and four measurement modules. The 
interface board consists of about 200 components and has dimensions of 98 x 
88 mm². On the measurement modules about 300 components are populated 
and its dimensions are 98 x 64 mm². 
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The processing of this differential voltage signal is split into 
two different paths. The green colored block indicates the EMG 
signal processing and the red block the bioimpedance 
measurement circuitry. 
In the green EMG block, the differential voltage is pre-
amplified and converted into a single-ended signal by an 
instrumentational amplifier (INA, INA126, Texas Instruments, 
Dallas, TX, US, G=11). To remove the high frequency signal 
components, caused by the bioimpedance measurement, the 
signal is filtered by an active low-pass filter (LPEMG, N=2, 
fc=100 Hz, G=5). Afterwards, the DC voltage component is 
removed by a passive high-pass filter (HPEMG, N=1, fc=3 Hz) 
and the signal is transmitted to the analog-to-digital converter 
(ADC, ADS131E06, Texas Instruments, Dallas, TX, US). 
In the red BioZ block, the acquired differential voltage is 
connected to an analog switch (SW1, ADG1236, Analog 
Devices, Norwood, MA, US), which can be used to choose 
between measuring the voltage drop over the bioimpedance or 
over the shunt resistor to determine the actual measurement 
current. The selected signal is amplified by a programmable 
gain amplifier (PGA1, AD8250, Analog Devices, Norwood, 
MA, US, G={1, 2, 5, 10}) and high-pass-filtered (HPIQ, N=1 
fc=1 kHz) to attenuate low-frequency noise and the DC voltage, 
caused by the electrodes’ half-cells. Afterwards, the signal is 
amplified by the PGA2 (AD8250). For the IQ-demodulation, 
the signal’s In-phase (I) and Quadrature (Q) components have 
to be determined [20]. Therefore, the signal passes two separate 
paths. In both the paths, analog switches (SW2, SW3, 
MAX4523, Maxim Integrated, San Jose, CA, US) alternate 
between the original and the inverted signal, clocked by the 
microcontroller with the current excitation signal frequency. 
The clock signals (CLKI, CLKQ) are phase shifted by 90° to 
realize the IQ-demodulation method [20]. Since only the 
occurring time dependent DC components of both the switching 
outputs contains the useful information, the signals are low pass 
filtered (LPI, LPQ, N=6, fc=1 kHz) before digitization. 
The analog processed EMG, the I-component as well as the 
Q-component signals are digitized synchronously by the 6-
channels ADC with a sampling rate of 1000 SPS and a 
resolution of 24 bits. The remaining three ADC channels are 
prepared for future use purposes. Via a serial peripheral 
interface (SPI), the ADC transmits the digitized data to the 
microcontroller. 
C. Implementation 
To realize the interface board as well as the measurement 
modules, 4-layers printed circuit boards (PCB) have been 
developed, as shown in the photograph in Fig. 4. To control the 
device and to display the measured data in real-time, a graphical 
user interface (GUI) has been programmed in C# language. A 
screenshot is depicted in Fig. 5. Since it is assumed, that during 
a measurement the applied excitation current is stable, the GUI 
automatically measures the current just once at the end of a 
measurement procedure. For that purpose, it changes the 
position of SW1 to the shunt resistor. 
The excitation frequency of each measurement module can 
be chosen from 17 discrete values in the range from 50 kHz to 
333 kHz. To keep the occurring voltage drops over the 
bioimpedances in the range of typical EMG signals as well as 
for electrical safety purposes, the excitation current amplitudes 
are limited and can be chosen from 11 discrete values in the 
range from 100 µA to 1 mA. Selectable total PGA gains for the 
voltage measurement are G=1; 2; 4; 5; 10; 25; 50; 100. 
The total power consumption with all four active channels is 
about 5.5 W, whereas each measurement module consumes 
about 1 W. 
IV. SYSTEM PERFORMANCE 
Before performing measurements on subjects, the system 
performance has to be analyzed. This includes the 
determination of measurement errors such as systematic, 
statistical as well as the system’s long-term drift errors. Finally, 
the synchronicity of all measurement channels is verified. 
 
Fig. 5.  Screenshot of the GUI to control the measurement system and to display the acquired data in real-time. Each column shows the six digitized signals of 
a measurement module. On the right side, the configuration window is shown. It can be used to change the frequency and amplitude of the excitation current as 
well as for configuring the gain of the programmable gain amplifiers. 
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A. Systematic Errors 
Since especially the impedance changes over time are of 
interest, in many bioimpedance measurement applications the 
systematic error is not as important as the statistical error. 
Nevertheless, the system’s systematic errors were analyzed by 
measuring known impedances in the range from magnitudes 
|Z|=2.7Ω to 1000 Ω and from phase shifts ϕ=0° to ϕ=-45°. The 
tolerances of the used impedances are 0.1 % and 0.1°, 
respectively.  To eliminate the influence of the statistical errors 
during this process, each impedance was measured for a 
duration of 1 s, corresponding to 1000 samples and then 
averaged. Since in this work the system cannot be characterized 
for all possible configurations, only one combination of 
excitation current and frequency was used. The excitation 
signal was chosen to be I=1 mA with a frequency of f=100 kHz. 
In Fig. 6 the true impedances as well as the measured values 
are plotted. To analyze if the actual magnitude or phase of the 
impedance under test has an influence to the systematic error, 
both were varied. Table I summarizes the obtained values of the 
absolute and relative systematic measurement errors under the 
variation of the magnitude and the phase. 
The relative magnitude errors were measured to be lower 
than 2 ‰ and the phase errors are below 0.2° in the range from 
7.3 Ω to 373.6 Ω. These values are in the range of the tolerances 
of the used test impedances. The observed systematic errors are 
sufficient for the intended application. 
B. Statistical Errors 
Especially for detecting the expected impedance changes 
reliably, it is important to determine the statistical errors of the 
system. For this purpose, the known test impedances are 
measured similarly as for the systematic error measurement but 
with a focus on statistical errors. In Fig. 7, an exemplary 
measurement with a duration of 3 s of one of these impedances 
is shown. 
For calculating the standard deviations (STD) of the 
magnitudes and phases, measurements with durations of 1 s are 
used. 
In Table II, the obtained values are again shown under 
variation of the impedance’s magnitude and phase. Since it is 
assumed that muscle contractions cause impedance changes in 
Ω-ranges [18], the standard deviation of maximum 202 mΩ is 
sufficiently small. The standard deviation of the phase 
measurement for all setups is lower than 0.03°. The results in 
the table II also show, that the standard deviations of the 
magnitude as well as of the phase do not significantly depend 
on the absolute values of the analyzed impedance. 
C. Long-Term Drift 
To estimate the long-term drift of the device, a measurement 
of a 7.3 Ω test impedance with a phase of -25.7° was performed 
for a duration of 20 minutes. The absolute drift during this time 
period was determined to be lower than 0.5 mΩ according to 
 
Fig. 6.  Plot of 48 actual impedance values (blue circles) and measured values 
(red crosses). Each value was measured for a duration of 1 s and averaged. The 
excitation current was chosen to be 1 mA with a frequency of 100 kHz. 
 
Fig. 7.  Exemplary measurement of a complex impedance over 3 s, 3000 
samples respectively. The true values are |Z|=138.1 Ω; ϕ(Z)=-14.8°. The 





|Z|true / Ω 2.7 7.3 19.5 52.1 139.6 373.6 1000 
ϕtrue 0° 0° 0° 0° 0° 0° 0° 
Gain 25 25 25 25 10 4 1 
STD(|Z|) / mΩ 0.55 1.2 4.1 9.5 23 74 202 
STD(|Z|) / ppm 204 164 210 182 165 198 202 
STD(ϕ) / ° 0.017 0.017 0.018 0.023 0.023 0.016 0.025 
|Z|true / Ω 139.6 139.6 139.6 139.6 139.6 139.6 139.6 
ϕtrue 0° -2.7° -4.8° -8.4° -14.6° -25.7° -45° 
Gain 10 10 10 10 10 10 10 
STD(|Z|) / mΩ 23 20 24 22 20 14 12 
STD(|Z|) / ppm 165 143 172 158 143 100 86 





|Z|true / Ω 2.7 7.3 19.5 52.1 139.6 373.6 1000 
ϕtrue 0° 0° 0° 0° 0° 0° 0° 
Gain 25 25 25 25 10 4 1 
|ΔZ| / mΩ 4.8 10 35 78 177 392 201 
|ΔZ| / ‰ 1.8 1.4 1.8 1.5 1.3 1.0 0.2 
|Δϕ| / ° 0.55 0.18 0.09 0.08 0.01 0.09 0.3 
|Z|true / Ω 139.6 139.6 139.6 139.6 139.6 139.6 139.6 
ϕtrue 0° -2.7° -4.8° -8.4° -14.6° -25.7° -45° 
Gain 10 10 10 10 10 10 10 
|ΔZ| / mΩ 177 146 158 147 162 109 67 
|ΔZ| / ‰ 1.3 1.0 1.1 1.1 1.2 0.8 0.5 
|Δϕ| / ° 0.01 0.07 0.03 0.00 0.02 0.11 0.01 
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57 ppm. The phase drifted during this time span about 0.007°. 
D. Synchronicity 
The synchronicity of all impedance and EMG channels is 
mandatory to be lower than 100 ms to enable prostheses or 
other devices to react within a time-span which might be 
acceptable for the user. Additionally, the synchronicity avoids 
misinterpretations of movements if the signals change very 
quickly. 
To generate a signal step and to measure it with all channels 
simultaneously, a setup as shown in Fig. 8 was used. In this 
setup, the resistor R2 represents a bioimpedance, which is 
measured by the four measurement modules. In this figure IBioZ 
represents the four current sources which apply currents of 
100 µA each through R2. To enable the separation of the 
channels, different excitation frequencies were used 
(f1=91 kHz, f2=100 kHz, f3=111 kHz, f4=125 kHz). 
Accordingly, VMeas. represents the voltage measurement 
sections of all the four modules. To generate an artificial EMG 
signal, VEMG was realized by using a signal generator 
(SDG1050, Siglent, Helmond, NL), which generated an AC 
voltage of 1 Vpp with a frequency of 70 Hz. R1 realized in 
combination with R2 a 10:1 voltage divider to decrease the 
artificial EMG voltages to suitable values. To generate signal 
steps, the switch SW1 was opened and closed alternately. 
In Fig. 9, the resulting measured signals of the impedance 
magnitudes and artificial EMG voltages are shown. The plot 
displays all eight signals. The switch SW1 was opened after 
about 0.3 s for a duration of about 0.4 s and closed again. It can 
be seen, that the four EMG signals as well as the four 
bioimpedance signals are that synchronous, that the plots are 
one above the other and it looks as if there are just two signals 
plotted. Also the time delay between the measured EMG signal 
step and the bioimpedance step is below 10 ms and therefore 
sufficiently short. 
V. MEASUREMENTS 
Measurements were performed on a human subject to 
demonstrate the usability of the measurement system. After 
comparing real EMG and EIM data with each other, the 
robustness of both signals towards mechanical interferences is 
analyzed. Finally, a set of typical hand gestures is measured by 
using all available measurement channels. 
A. Comparison between EMG and BioZ-Signals 
Previous publications focus either on the EMG or on the EIM 
signals [13], [15], [21], [22]. The relationship between both the 
signals, especially the timing behavior has not been investigated 
reliably, so far. Therefore, a muscle contraction of the forearm, 
as shown on top of Fig. 10 was performed. To acquire the 
signals directly above the musculus flexor carpi radialis, four 
Ag/AgCl gel electrodes (Kendall H92SG, Covidien, Dublin, 
IE) were placed on the forearm and connected to a measurement 
module as depicted in the figure. The distance between the 
voltage electrodes was measured to be 3 cm. 
The configured bioimpedance excitation current was 100 µA 
with a frequency of 100 kHz and the chosen gain was G=25. 
Within the measurement time span of four seconds, the 
muscle contraction was performed two times for durations of 
 
Fig. 9.  Acquired step response of the four bioimpedance measurement 
channels as well as the four EMG channels. Because of the high synchronicity 
and precision, the plot seems to display just two signals. The time delay 
between the EMG channels and the bioimpedance channels was determined to 
be lower than 10 ms. 
  
 
Fig. 8.  Setup to generate simultaneous impedance and EMG signal steps to 
analyze the systems’ synchronicity. In this figure each, the IBioZ and VMeas. 
represent the four channels of the four measurement modules. 
  
 
Fig. 10.  Measurement setup to acquire the muscle contraction during wrist 
flexions and a plot of the measured raw data of the EMG signal and the 
complex bioimpedance. The muscle contraction was performed two times. In 
comparison to the EMG signal, it can be seen, that especially the beginning of 
the contraction can also easily be detected by performing bioimpedance 
measurements. 
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about 0.5 s and 1.3 s. 
The acquired unfiltered data of the EMG signal (black), the 
bioimpedance magnitude (blue) and the bioimpedance phase 
(red) are shown in the plot in Fig. 10. For comparison purposes, 
the EMG signal is plotted in arbitrary units.  
Both contractions can clearly be seen in the morphology of 
the EMG signal. It is also distinguishable, that during these 
contractions, the magnitude of the bioimpedance decreases 
from about 27.7 Ω to approximately 25.4 Ω. During this time 
period, the phase shift increases by about 0.7°. It can be seen 
that the slopes of the impedance signals begin simultaneously 
with the EMG signals. After approximately 100 ms the 
bioimpedance values reach a constant state, which indicates the 
end of the movement and therefore the end of geometrical 
muscle changes. After contractions, the bioimpedance signals 
need more time to reach to original values, which might be 
caused by the different signal origins. 
This measurement demonstrates that the acquisition of the 
complex bioimpedance, simultaneously to EMG signals, 
provides additional useful information. 
B. Robustness towards Mechanical Disturbances 
The most promising advantage of the additional 
bioimpedance recording is its robustness towards electrode 
motion artifacts. By only evaluating the occurring voltage 
signals of the known excitation frequency, interferences of all 
other signals with different frequencies can be eliminated. 
To evaluate this beneficial effect, the measurement of the 
section above was repeated under the same conditions. In 
addition to contracting the forearm muscle two times, 
mechanical disturbances were applied to the positive voltage 
electrode to generate changes in the half-cell voltage. These 
minuscule vibrations were generated by slipping the clamping 
mechanism of a cordless screwdriver on the electrode with an 
intensity which produces disturbances in the range of the actual 
EMG signal. 
In Fig. 11 the acquired three raw signals are displayed. 
During the two performed muscle contractions, the signals 
show up as before. During the two additional periods (11-14 s; 
15-18.5 s), the previously described external force was applied 
to the electrodes. While the EMG trace shows strong 
interferences with amplitudes similar to the former EMG 
signals, the EIM magnitude |Z| is only slightly affected at the 
onset of the mechanical disturbances. The EIM phase however 
remains not influenced.  
C. 4-Channel-Measurement for Prosthesis Control 
In many applications, for instance prostheses control, it is 
desirable to analyze several muscle groups simultaneously. 
Especially, the geometrical depth of the impedance 
measurement needs to be considered. If thus particular muscle 
regions cannot be selected by a single set of electrodes reliably 
the simultaneous use of several electrode sets could be useful. 
To demonstrate the system’s capability to distinguish more 
complex activations of muscle groups, measurements utilizing 
all four available measurement modules were performed on a 
human forearm. The chosen positions of the Ag/AgCl gel 
electrodes are shown in Fig. 12. The excitation currents of the 
modules were 200 µA and to separate the channels from each 
other, different excitations frequencies were chosen 
(f1=91 kHz, f2=100 kHz, f3=111 kHz, f4=125 kHz). 
To verify whether the bioimpedance signal provides 
additional information or if it is just redundant to the EMG 
signal, several typical wrist movements were performed by the 
subject. The chosen five movements are shown on the top of 
Fig. 13. Under the corresponding photographs of the 
movements, the acquired data of the four EMG, |Z| and ϕ(Z) 
channels are shown. Only the EMG signal is filtered by a zero-
phase notch filter to reduce the 50 Hz interferences. No further 
digital filtering is performed to the signals. For a more 
convenient perception, offsets are added to the EMG signals. 
The magnitude and phase plots present the occurring changes 
in percent and in degrees, respectively. 
 Every performed muscle contraction was started after 1 s for 
a duration of about 2 s. These periods can easily be 
distinguished in all signal plots. 
Comparing the five impedance magnitude plots leads to the 
assumption that the channel decoupling in this measurement 
setup is sufficient. This is especially visible when focusing for 
example on the signals of the channels CH2 (red) and CH3 
(yellow) with adjacent electrodes and similar frequencies of the 
first (WF) magnitude plot. Even when both sets of electrodes 
and thus the corresponding bioimpedances are close to each 
other, the behavior of the signals is completely different. 
 
Fig. 11.  Measurement results of two performed muscle contraction of the 
forearm flexor muscle and two artificially applied mechanical disturbances to 
the positive voltage electrode. It can be seen that the applied vibrations affect 
the EMG signal significantly, whereas the bioimpedance magnitude and phase 
do almost not change during these time periods. 
  
 
Fig. 12.  Positioning of the 16 Ag/AgCl gel electrodes for performing 
measurements with four measurement modules. The distance between related 
voltage electrodes is about 4 cm.  
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To check if the information of the EMG data and the 
corresponding impedance magnitudes is same, the plots of the 
wrist flexion (WF) and extension (WE) can be compared. It can 
be seen that the EMG behavior of CH1 (blue) during both the 
movements has a similar behavior. In contrast, the 
corresponding impedance magnitude signals of CH1 differ 
completely from each other. The same effect can be found when 
comparing the EMG data with the impedance phase signal. For 
example, the EMG signals of CH4 look similar during the WE 
and the HO motion, whereas the behavior of the corresponding 
impedance phases is opposite during both the muscle 
contractions. Finally, comparing the impedance magnitude and 
phase plots in the same way, leads to the result, that acquiring 
EMG, bioimpedance magnitude and phase provides three 
independent fully redundant sets of information per 
measurement channel. 
D. Measurement of Isometric Muscle Contractions 
The previously presented measurements were performed 
during actual movements. In some applications it might also be 
interesting to detect isometric muscle contractions without 
significant geometrical changes within the tissue under test. To 
give an impression about the occurring bioimpedance signals 
during these kind of muscle contractions, the previously shown 
measurement was repeated for the wrist flexion and extension. 
Both contractions were performed against solid plates, as 
shown at the top of figure 14, to avoid changes in the angle 
between the forearm and the hand. The occurring forces Fiso 
during the contractions were measured to be 20±3 N. Both 
contractions were performed two times for a duration of about 
2 s. 
In the corresponding EMG plots in figure 14, it can be seen 
that the signal behavior is similar to the previously presented 
results of the non-isometric wrist flexion and extension. The 
 
Fig. 13.  Measurement result of five typical hand gestures, using the four measurement modules simultaneously. Each muscle contraction was performed for a 
duration of about 2 s. In the plots below the corresponding photographs, the EMG signals as well as the bioimpedance magnitudes and phases are shown. The 
EMG data was preprocessed by a digital 50 Hz notch filter, whereas the impedance signals have not been filtered digitally. Comparing the resulting plots leads 
to the conclusion that the magnitude and phase signals of the bioimpedance provide additional useful information about muscle contractions. Additionally, hand 
gestures which are difficult to detect via EMG measurements, for example the hand rotation (HR), can be recognized via bioimpedance measurements reliably.  
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isometric contractions do also cause significant changes of the 
bioimpedance magnitude and phase signals. In comparison to 
the results in figure 13, the relative changes of the 
bioimpedance magnitudes and the phase shifts are lower. Some 
signals, such as CH3, have a very similar behavior during 
isometric and non-isometric contractions. However, the signal 
of CH2 behaves very different in both cases. This might be 
caused by the different kinds of geometrical changes within the 
tissue, but has to be analyzed more detailed in the future. 
VI. DISCUSSION 
The EMG and the EIM, though both deployed to detect 
muscle activations, do differ with respect to their physiologic 
origins. EMG represents the bioelectrical signal of the muscle 
contraction caused by the muscle cells’ activation potentials.  
The impedance signal however, is induced by the geometrical 
changes of the muscle. Either during active contraction or 
during passive expansion. Therefore, both the signals do not 
strictly depend on each other. Since there is usually a time delay 
between muscle activation and its geometrical reaction [23], the 
bioimpedance signal is delayed against the EMG signal. This 
delay is visible in the exemplary measurement shown in 
Fig. 10. It occurs in a range of tens of milliseconds and it 
depends on the particular application, if such delays are 
acceptable. 
The measurement, in Fig. 11 has demonstrated that the 
sensitivity regarding mechanical disturbances of the voltage 
electrodes is much lower in bioimpedance measurements than 
in EMG signals. Nevertheless, the conditions of the electrode 
skin contacts in EIM applications is important as well. High 
interface impedances of the current electrodes lead to high 
voltage drops over the electrode skin impedances. This issue 
has a significant impact on the design of the current source as 
well as on the voltage measurement circuit [24]. The usage of 
dry electrodes, as preferred in prostheses, with commonly high 
electrode skin impedances aggravates this issue [25], [26]. But 
lower excitation currents or higher excitation frequencies can 
help to keep the voltage drop over the mainly capacitive 
impedances under a tolerable limit. 
The measurement results shown in Fig. 13 are very 
promising. They support that the additional bioimpedance 
measurement triples the amount of usable information. In this 
particular example, 12 signals are available to detect the muscle 
contractions in the forearm. Even in situations in which the 
EMG signals are poor, it seems that the bioimpedance 
measurements provide useful information. The information of 
both kinds of signals can be combined by applying machine 
learning algorithms. The results in figure 14 show that the 
bioimpedance magnitude and phase change also during 
isometric contractions. 
It has to be noted, that all measurements in this work were 
performed in a laboratory environment. Further disturbances 
such as the mechanical interactions between the electrodes and 
the muscles were not investigated. It is conceivable that 
changes of the limb position can lead to impedance changes as 
well. Exhaustive studies on subjects are mandatory to analyze 
the influence of the electrode-skin interfaces and the electrode 
positions on the measurement results. 
Furthermore, the anisotropic behavior of the muscles’ 
impedance has not been analyzed in this work. This behavior 
could also be a useful information to differentiate between 
motion artifacts and actual muscle contractions. 
To assess the actual benefit of the additional bioimpedance 
signals for different prostheses situations as well as for other 
applications, more studies with extended subject sets and 
typical environmental noise situations are envisaged for the 
future. 
VII. CONCLUSION 
In this work we presented an approach to acquire EMG and 
EIM information about muscle contractions from several 
positions of a subject, simultaneously. 
A modular multi-channel measurement device was 
developed and characterized. In addition to an ordinary EMG 
system, this device is capable of acquiring bioimpedance 
magnitude changes in mΩ ranges and phase changes smaller 
than 0.05°. 
First measurements from a human subject have shown the 
differences between EMG and EIM signals with a focus on their 
timing relationships. Additionally, the robustness of 
 
Fig. 14.  Measurement of two typical hand gestures. To enable isometric 
muscle contractions, the movements were performed against solid plates with 
a force of approximately 20 N. 
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bioimpedance measurements towards mechanical disturbances 
to the electrodes was demonstrated. 
Finally, the combination of four measurement modules was 
used to analyze typical hand gestures by combining EMG and 
bioimpedance measurements. The results demonstrated the 
usefulness of acquiring the bioimpedance to detect muscle 
motions, especially for prosthesis controls. But many other 
human-machine interface applications are conceivable as well. 
Even when the proposed results are very promising, further 
studies on the influence of the electrodes’ behavior and 
positions have to be performed. 
In the future, existing algorithms have to be adapted to 
combine the signals and to convert them into a movement 
information, automatically. 
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